Browsing: right

Los legisladores de Kentucky están considerando expandir la Ley de Derecho a Intentar del estado, que permitirĂ­a a más pacientes acceder a tratamientos experimentales no aprobados por la FDA, incluyendo aquellos con enfermedades graves que no sean necesariamente terminales. Los defensores de esta expansiĂłn argumentan que darĂ­a a los pacientes y sus familias opciones adicionales…

Comparing the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the VanEck Biotech ETF (NASDAQ:BBH) reveals two distinct fund profiles. IHE tracks established, blue chip pharmaceutical companies, while BBH zeroes in on the research-intensive biotech space. Here’s how those different strategies stack up in terms of cost, yield, and risk

Nearly half of all American adults have high blood pressure. That represents roughly 120 million people, and most will eventually be encouraged to take medication. But blood pressure roulette is an uncomfortable way to describe what often happens next: a doctor chooses a drug, writes a prescription and waits to see what happens. Will it…